Bushu Pharmaceuticals
Manufacturing · Japan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Takeno, Takeno, Saitamaken, 350-0801, ...Phone Number
+81 492419000Website
www.bushu-pharma.comRevenue
$12.8 MillionIndustry
About Bushu Pharmaceuticals
Bushu Pharmaceuticals Org Chart
Is Bushu Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Bushu Pharmaceuticals is spiking on competitors!
Earning: See what the market has to say on Bushu Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Bushu Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Bushu Pharmaceuticals
Check if Bushu Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Bushu Pharmaceuticals has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Bushu Pharmaceuticals launches new products
Click to see if Bushu Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Bushu Pharmaceuticals
Find more new buyers
Company Profile Activity
Activity Insights
Bushu Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bushu Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bushu Pharmaceuticals.
Bushu Pharmaceuticals Tech Stack
A closer look at the technologies used by Bushu Pharmaceuticals
Most Recent Scoops
Bushu Pharmaceuticals News & Media
Bushu Pharma Applauded by Frost & Sullivan for Offering Customer Value in APAC CDMO Industry Through Consistent Quality Assurance, On-time Delivery, Sustainability, and Competitive Costs
Bushu Pharma's ongoing investments and efforts offer customers state-of-the-art capabilities, increased capacity, and innovative solutions, providing top-tier pharmaceutical manufacturing and supply chain management services. SAN ANTONIO, Dec. 15, 2024 /PRNewswire/ -- Frost & Sullivan researched the contract development and manufacturing organization industry and, based on its analysis, recognizes Bushu Pharmaceuticals (Pharma) with the 2024 APAC Customer Value Leadership Award. The company is aKKR to buy Japan's Bushu Pharmaceuticals in $749m deal
KKR to buy Japan's Bushu Pharmaceuticals in $749m deal Submitted 20/12/2022 - 10:54am Private equity giant KKR & Co Inc has revealed plans to acquire Japanese drug developer Bushu Pharmaceuticals from BPEA EQT, a Hong Kong-based private equity firm, according to a report by Reuters. While financial details of the deal have not been revealed, the report cites unnamed sources as revealing that a Bloomberg report published in August suggested a transaction may value BushuKKR to Acquire Bushu Pharmaceuticals
TOKYO & SAITAMA, Japan--(BUSINESS WIRE)--KKR to Acquire Bushu PharmaceuticalsBushu Pharma Lauded by Frost & Sullivan for Enabling the Launch of Specialty Drugs in Japan and Asia-Pacific and Offering Customer Value with Its Advanced Gateway to Asia Services
The Gateway to Asia initiative ensures quality and timely delivery through shorter lead times, temperature and humidity control, and streamlined urgent order processing SAN ANTONIO, July 27, 2022 /PRNewswire/ -- Based on its recent analysis of the pharmaceutical supply chain contract...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bushu Pharmaceuticals
武州製薬株式会社 is a specialized CDMO (Contract Development and Manufacturing Organization) with over 25 years of experience in pharmaceutical contract manufacturing, holding GMP certifications from major countries worldwide. The company caters to a global market, exporting to 56 countries, and focuses on producing solid dosage forms, injectable products,... Read More